NASDAQ:BRLI - Bio-Reference Laboratories Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.

Receive BRLI News and Ratings via Email

Sign-up to receive the latest news and ratings for BRLI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
SymbolNASDAQ:BRLI
CUSIP09057G60
Phone+1-201-7912186

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.67%
Return on Equity12.67%
Return on Assets8.38%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

Bio-Reference Laboratories (NASDAQ:BRLI) Frequently Asked Questions

What is Bio-Reference Laboratories' stock symbol?

Bio-Reference Laboratories trades on the NASDAQ under the ticker symbol "BRLI."

How were Bio-Reference Laboratories' earnings last quarter?

Bio-Reference Laboratories Inc (NASDAQ:BRLI) released its quarterly earnings results on Thursday, December, 18th. The medical research company reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.63 by $0.03. The medical research company had revenue of $227.60 million for the quarter, compared to analysts' expectations of $228.81 million. Bio-Reference Laboratories had a net margin of 4.67% and a return on equity of 12.67%. The company's revenue was up 18.4% compared to the same quarter last year. During the same period last year, the business earned $0.40 EPS. View Bio-Reference Laboratories' Earnings History.

How do I buy shares of Bio-Reference Laboratories?

Shares of BRLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bio-Reference Laboratories' official website?

The official website for Bio-Reference Laboratories is http://www.bioreference.com.

How can I contact Bio-Reference Laboratories?

Bio-Reference Laboratories' mailing address is 481 Edward H Ross Dr, ELMWOOD PARK, NJ 07407-3118, United States. The medical research company can be reached via phone at +1-201-7912186.


MarketBeat Community Rating for Bio-Reference Laboratories (NASDAQ BRLI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  162
MarketBeat's community ratings are surveys of what our community members think about Bio-Reference Laboratories and other stocks. Vote "Outperform" if you believe BRLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRLI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2018 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel